Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia

NCT00232024 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1296
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis